Indivior Pharmaceuticals (INDV) Property, Plant & Equipment (Net) (2021 - 2026)
Indivior Pharmaceuticals (INDV) Property, Plant & Equipment (Net) (2021 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | 37.35 Bn |
| 2 | Teva Pharmaceutical Industries | 35.88 Bn | 32.14 Bn | 1.97 Bn | 4.00 Bn |
| 3 | Zoetis | 32.64 Bn | 30.70 Bn | 1.62 Bn | 3.72 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 13.52 Bn |
| 5 | United Therapeutics | 23.04 Bn | 20.88 Bn | 648.10 Mn | 1.84 Bn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | 49,000.00 |
| 7 | Viatris | 20.37 Bn | 18.57 Bn | 1.16 Bn | 2.53 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.45 Bn | 800.70 Mn | 90.90 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 1.40 Bn |
| 10 | Indivior Pharmaceuticals | 4.99 Bn | 4.82 Bn | 277.00 Mn | 157.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 157.00 Mn |
| Mar 31, 2026 | 157.00 Mn |
| Dec 31, 2025 | 144.00 Mn |
| Dec 31, 2025 | 144.00 Mn |
| Sep 30, 2025 | 124.00 Mn |
| Sep 30, 2025 | 124.00 Mn |
| Jun 30, 2025 | 117.00 Mn |
| Jun 30, 2025 | 117.00 Mn |
| Mar 31, 2025 | 104.00 Mn |
| Mar 31, 2025 | 104.00 Mn |
| Dec 31, 2024 | 100.00 Mn |
| Dec 31, 2024 | 100.00 Mn |
| Dec 31, 2023 | 84.00 Mn |
| Dec 31, 2023 | 84.00 Mn |
| Dec 31, 2022 | 54.00 Mn |
| Dec 31, 2022 | 54.00 Mn |
| Dec 31, 2021 | 388.00 Mn |
| Dec 31, 2021 | 388.00 Mn |